What we found on the web about Glargine
Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with ...
2003 Aventis Lantus "glargine" insulin analogue approved in USA [9] 2004 Sanofi Aventis Apidra insulin "glulisine" analogue approved for clinical use in the USA.
Insulin Glargine (In-sue-lin glaa-jean) is a medicine which is used in diabetes. It is available in the following preparations: Insulin glargine 100units/ml solution for injection ...
Consumer information about the medication INSULIN GLARGINE - INJECTABLE (Lantus), includes side effects, drug interactions, recommended dosages, and storage information. Read more ...
What is the most important information I should know about insulin glargine? ... What is the most important information I should know about insulin glargine?
Children with Diabetes is the online community for parents, kids, adults, and families living with type 1 diabetes. ... Use of insulin glargine during pregnancy. ...
Insulin glargine is a biosynthetic human insulin analog which has been developed ... In April 1999, HMR filed insulin glargine for approval in both Europe and the US ...
As this eMedTV page explains, the recommended insulin glargine dosage will vary, depending on several factors, such your current dose of other insulins and other medical conditions ...
Lantus is the brand name for insulin glargine, an insulin analog made by Aventis[10]. Lantus is a very long-acting insulin (lasting up to 24 hours in humans) that ...
Pet Health Information about cat care ... From ACVIM Web Abstracts, ABSTRACT #63 . INSULIN GLARGINE AND A HIGH PROTEIN-LOW CARBOHYDRATE DIET ARE ASSOCIATED WITH HIGH REMISSION ...
Even though glargine is a long acting insulin, it probably will need to be given ... Glargine insulin cannot be diluted. ... if one attempts to dilute glargine. ...
Protein hormone, produced by specialized cells in the islets of Langerhans in the pancreas, which regulates the metabolism (rate of activity) of glucose, fats, and proteins.
FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes.
However, because glargine and detemir differ from one another, further clinical ... Glargine shows less day-to-day variability than does either neutral protamine ...
Pet Health Information ... INSULIN GLARGINE AND A HIGH PROTEIN-LOW CARBOHYDRATE DIET ARE ... 6 cats treated with glargine went into diabetic remission within ...
Achieving regulation in the diabetic cat can be tricky. In most cats, finding an insulin that lasts long enough is a substantial problem. PZI insulin has been withdrawn from the ...
Insulin glargine is only part of a complete program of treatment that may also include diet, exercise, weight control, foot care, eye care, dental care, and testing your blood ...
Lantus® (insulin glargine) is a synthetic long-lasting insulin product. It is now on the market in many countries. Lantus® (insulin glargine) Class: insulin analog ...
While most people tolerate insulin glargine well, serious side effects can occur. This eMedTV resource takes an in-depth look at possible side effects of insulin glargine ...
insulin /in·su·lin/ (in´sdbobr-lin) 1. a protein hormone formed from proinsulin in the beta cells of the pancreatic islets of Langerhans. The major fuel-regulating hormone, it ...
Here is what users have to say about Glargine

Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. Its advantage is that it has a duration of action of 24 hours, with a "less peaked" profile than NPH. Thus, it more closely resembles the basal insulin secretion of the normal pancreatic beta cells. In type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin (Type 1 diabetes or depleted type 2), Lantus needs the support of a fast acting insulin taken with food to reduce the effect of prandially derived glucose. It is fasting glucose elevation which more significantly affects HbA1c and thus determines the progression of the long-term complications of diabetes mellitus .

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!